"10.1371_journal.pone.0146462","plos one","2016-01-08T00:00:00Z","Hsien-Yi Chiu; Chi-Feng Hsieh; Yi-Ting Chiang; Yi-Wen Tsai; Weng-Foung Huang; Cheng-Yuan Li; Ting-Shun Wang; Tsen-Fang Tsai","Institute of Biomedical Engineering, College of Medicine and College of Engineering, National Taiwan University, Taipei, Taiwan; Department of Dermatology, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan; Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Institute of Health and Welfare Policy, National Yang-Ming University, Taipei, Taiwan; Department of Dermatology, Taipei Veterans General Hospital, Taoyuan Branch, Taoyuan, Taiwan; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan; Division of Dermatology, National Taiwan University Hospital, Yun-Lin Branch, Dou-Liou, Taiwan","Conceived and designed the experiments: HYC CFH YTC YWT WFH CYL TSW TFT. Performed the experiments: HYC CFH YTC YWT WFH TFT. Analyzed the data: HYC CFH YTC YWT WFH CYL TSW TFT. Contributed reagents/materials/analysis tools: HYC CFH YTC YWT WFH TFT. Wrote the paper: HYC CFH YTC YWT WFH CYL TSW TFT.","Dr. Tsai has conducted clinical trials or received honoraria for serving as a consultant for Pfizer Pharmaceuticals, Serono International SA (now Merck Serono International), UniPharma/Biogen Idec, Galderma, Celgene, Novartis Pharmaceuticals and Janssen-Cilag Pharmaceutical, and has received speaking fees from AbbVie. Dr. Chiu has received speaking fees from AbbVie, Janssen-Cilag Pharmaceutical and Pfizer. Weng-Foung Huang has received research support from Novartis Pharmaceuticals. The other authors have no conflicts of interest to declare. This does not alter the authorsâ€™ adherence to PLOS ONE policies on sharing data and materials.","2016","01","Hsien-Yi Chiu","HYC",8,TRUE,8,6,8,8,TRUE,TRUE,FALSE,0,NA,FALSE
